Binding of complement regulators to invasive nontypeable Haemophilus influenzae isolates is not increased compared to nasopharyngeal isolates, but serum resistance is linked to disease severity

Journal of Clinical Microbiology

Volumn 48, Issue 3, 2010, Pages 921-927

  Hallström, Teresia ^a   Resman, Fredrik ^a,b   Ristovski, Mikael ^a   Riesbeck, Kristian ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C4B BINDING PROTEIN; COMPLEMENT FACTOR H; VITRONECTIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTEREMIA; BACTERIAL SURVIVAL; BACTERIUM ISOLATE; BLOOD CULTURE; BLOOD SAMPLING; BLOODSTREAM INFECTION; CHILD; CLINICAL ARTICLE; COMPLEMENT FIXATION; COMPLEMENT SYSTEM; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS MENINGITIS; HUMAN; IMMUNE DEFICIENCY; INFANT; MALE; NASOPHARYNGEAL ASPIRATION; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEPSIS; UPPER RESPIRATORY TRACT INFECTION;

ADULT; AGED; AGED, 80 AND OVER; BLOOD BACTERICIDAL ACTIVITY; CARRIER STATE; COMPLEMENT SYSTEM PROTEINS; FEMALE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; MALE; MICROBIAL VIABILITY; MIDDLE AGED; PROTEIN BINDING; SEPSIS;

HAEMOPHILUS INFLUENZAE;

EID: 77749340477     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01654-09     Document Type: Article

References (41)

1. Ahren, I. L., D. L. Williams, P. J. Rice, A. Forsgren, and K. Riesbeck. 2001. The importance of a beta-glucan receptor in the nonopsonic entry of nontypeable Haemophilus influenzae into human monocytic and epithelial cells. J. Infect. Dis. 184:150-158.
2. Aubrey, R., and C. Tang. 2003. The pathogenesis of disease due to type b Haemophilus influenzae. Methods Mol. Med. 71:29-50.
3. Bandi, V., M. A. Apicella, E. Mason, T. F. Murphy, A. Siddiqi, R. L. Atmar, and S. B. Greenberg. 2001. Nontypeable Haemophilus influenzae in the lower respiratory tract of patients with chronic bronchitis. Am. J. Respir. Crit. Care. Med. 164:2114-2119.
4. Bandi, V., M. Jakubowycz, C. Kinyon, E. O. Mason, R. L. Atmar, S. B. Greenberg, and T. F. Murphy. 2003. Infectious exacerbations of chronic obstructive pulmonary disease associated with respiratory viruses and non-typeable Haemophilus influenzae. FEMS Immunol. Med. Microbiol. 37:69-75.
5. Bath, S. 2002. Progress towards elimination of Haemophilus influenzae type b invasive disease among infants and children-United States 1998-2000. MMWR Morb. Mortal. Wkly. Rep. 51:234-237.
6. Blom, A. M. 2002. Structural and functional studies of complement inhibitor C4b-binding protein. Biochem. Soc. Trans. 30:978-982.
7. Blom, A. M., T. Hallstrom, and K. Riesbeck. 2009. Complement evasion strategies of pathogens-acquisition of inhibitors and beyond. Mol. Immunol. 46:2808-2817.
8. Bone, R. C., W. J. Sibbald, and C. L. Sprung. 1992. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 101:1481-1483.
9. Erwin, A. L., S. Allen, D. K. Ho, P. J. Bonthuis, J. Jarisch, K. L. Nelson, D. L. Tsao, W. C. Unrath, M. E. Watson, Jr., B. W. Gibson, M. A. Apicella, and A. L. Smith. 2006. Role of lgtC in resistance of nontypeable Haemophilus influenzae strain R2866 to human serum. Infect. Immun. 74:6226-6235.
10. Greenwood, F. C., W. M. Hunter, and J. S. Glover. 1963. The preparation of I-131-labelled human growth hormone of high specific radioactivity. Biochem. J. 89:114-123.
11. Greiff, L., M. Andersson, J. S. Erjefalt, C. G. Persson, and P. Wollmer. 2003. Airway microvascular extravasation and luminal entry of plasma. Clin. Physiol. Funct. Imaging 23:301-306.
12. Greiff, L., I. Erjefalt, C. Svensson, P. Wollmer, U. Alkner, M. Andersson, and C. G. Persson. 1993. Plasma exudation and solute absorption across the airway mucosa. Clin. Physiol. 13:219-233.
13. Groenewegen, K. H., and E. F. Wouters. 2003. Bacterial infections in patients requiring admission for an acute exacerbation of COPD; a 1-year prospective study. Respir. Med. 97:770-777.
14. Hallstrom, T., A. M. Blom, P. F. Zipfel, and K. Riesbeck. 2009. Nontypeable Haemophilus influenzae protein E binds vitronectin and is important for serum resistance. J. Immunol. 183:2593-2601.
15. Hallstrom, T., H. Jarva, K. Riesbeck, and A. M. Blom. 2007. Interaction with C4b-binding protein contributes to nontypeable Haemophilus influenzae serum resistance. J. Immunol. 178:6359-6366.
16. Hallstrom, T., E. Trajkovska, A. Forsgren, and K. Riesbeck. 2006. Haemophilus influenzae surface fibrils contribute to serum resistance by interacting with vitronectin. J. Immunol. 177:430-436.
17. Hallstrom, T., P. F. Zipfel, A. M. Blom, N. Lauer, A. Forsgren, and K. Riesbeck. 2008. Haemophilus influenzae interacts with the human complement inhibitor factor H. J. Immunol. 181:537-545.
18. Heinen, S., A. Hartmann, N. Lauer, U. Wiehl, H. M. Dahse, S. Schirmer, K. Gropp, T. Enghardt, R. Wallich, S. Halbich, M. Mihlan, U. Schlotzer-Schrehardt, P. F. Zipfel, and C. Skerka. 2009. Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation. Blood 114:2439-2447.
19. Ho, D. K., S. Ram, K. L. Nelson, P. J. Bonthuis, and A. L. Smith. 2007. lgtC expression modulates resistance to C4b deposition on an invasive nontypeable Haemophilus influenzae. J. Immunol. 178:1002-1012.
20. Kilian, M. 2003. Haemophilus, p. 623-635. In P. R. Murray (ed.), Manual of clinical microbology, vol. 8. ASM Press, Washington, DC.
21. Kirjavainen, V., H. Jarva, M. Biedzka-Sarek, A. M. Blom, M. Skurnik, and S. Meri. 2008. Yersinia enterocolitica serum resistance proteins YadA and ail bind the complement regulator C4b-binding protein. PLoS Pathog. 4:e1000140.
22. Lambris, J. D., D. Ricklin, and B. V. Geisbrecht. 2008. Complement evasion by human pathogens. Nat. Rev. Microbiol. 6:132-142.
23. Mukundan, D., Z. Ecevit, M. Patel, C. F. Marrs, and J. R. Gilsdorf. 2007. Pharyngeal colonization dynamics of Haemophilus influenzae and Haemophilus haemolyticus in healthy adult carriers. J. Clin. Microbiol. 45:3207-3217.
24. Murphy, T. F., A. L. Brauer, S. Sethi, M. Kilian, X. Cai, and A. J. Lesse. 2007. Haemophilus haemolyticus: a human respiratory tract commensal to be distinguished from Haemophilus influenzae. J. Infect. Dis. 195:81-89.
25. Murphy, T. F., H. Faden, L. O. Bakaletz, J. M. Kyd, A. Forsgren, J. Campos, M. Virji, and S. I. Pelton. 2009. Nontypeable Haemophilus influenzae as a pathogen in children. Pediatr. Infect. Dis. J. 28:43-48.
26. Narkio-Makela, M., J. Hellwage, O. Tahkokallio, and S. Meri. 2001. Complement-regulator factor H and related proteins in otitis media with effusion. Clin. Immunol. 100:118-126.
27. Narkio-Makela, M., J. Jero, and S. Meri. 1999. Complement activation and expression of membrane regulators in the middle ear mucosa in otitis media with effusion. Clin. Exp. Immunol. 116:401-409.
28. Patel, I. S., T. A. Seemungal, M. Wilks, S. J. Lloyd-Owen, G. C. Donaldson, and J. A. Wedzicha. 2002. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax 57: 759-764.
29. Persson, C. G., I. Erjefalt, U. Alkner, C. Baumgarten, L. Greiff, B. Gustafsson, A. Luts, U. Pipkorn, F. Sundler, C. Svensson, et al. 1991. Plasma exudation as a first line respiratory mucosal defence. Clin. Exp. Allergy 21:17-24.
30. Ronander, E., M. Brant, E. Eriksson, M. Morgelin, O. Hallgren, G. Westergren-Thorsson, A. Forsgren, and K. Riesbeck. 2009. Nontypeable Haemophilus influenzae adhesin protein E: characterization and biological activity. J. Infect. Dis. 199:522-531.
31. Rooijakkers, S. H., and J. A. van Strijp. 2007. Bacterial complement evasion. Mol. Immunol. 44:23-32.
32. Rosell, A., E. Monso, N. Soler, F. Torres, J. Angrill, G. Riise, R. Zalacain, J. Morera, and A. Torres. 2005. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease. Arch. Intern. Med. 165:891-897.
33. Schvartz, I., D. Seger, and S. Shaltiel. 1999. Vitronectin. Int. J. Biochem. Cell Biol. 31:539-544.
34. Sethi, S., and T. F. Murphy. 2008. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N. Engl. J. Med. 359:2355-2365.
35. St. Geme, J. W., III. 1993. Nontypeable Haemophilus influenzae disease: epidemiology, pathogenesis, and prospects for prevention. Infect. Agents Dis. 2:1-16.
36. Tsang, R. S., M. L. Sill, S. J. Skinner, D. K. Law, J. Zhou, and J. Wylie. 2007. Characterization of invasive Haemophilus influenzae disease in Manitoba, Canada, 2000-2006: invasive disease due to non-type b strains. Clin. Infect. Dis. 44:1611-1614.
37. Volanakis, J. E. 2001. Human C-reactive protein: expression, structure, and function. Mol. Immunol. 38:189-197.
38. Walport, M. J. 2001. Complement. First of two parts. N. Engl. J. Med. 344:1058-1066.
39. Weiser, J. N., and N. Pan. 1998. Adaptation of Haemophilus influenzae to acquired and innate humoral immunity based on phase variation of lipopolysaccharide. Mol. Microbiol. 30:767-775.
40. Williams, B. J., G. Morlin, N. Valentine, and A. L. Smith. 2001. Serum resistance in an invasive, nontypeable Haemophilus influenzae strain. Infect. Immun. 69:695-705.
41. Zipfel, P. F., C. Skerka, J. Hellwage, S. T. Jokiranta, S. Meri, V. Brade, P. Kraiczy, M. Noris, and G. Remuzzi. 2002. Factor H family proteins: on complement, microbes and human diseases. Biochem. Soc. Trans. 30:971-978.